Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant

We performed a phase I/II trial in North America of a recombinant surfactant protein C-based surfactant (Venticute) as treatment for the acute respiratory distress syndrome. Patients were prospectively randomized to receive either standard therapy or standard therapy plus one of two doses of exogeno...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of respiratory and critical care medicine 2003-06, Vol.167 (11), p.1562-1566
Hauptverfasser:	Spragg, Roger G, Lewis, James F, Wurst, Wilhelm, Hafner, Dietrich, Baughman, Robert P, Wewers, Mark D, Marsh, James J
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Bronchoalveolar Lavage Fluid - chemistry Female Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Pulmonary Surfactant-Associated Protein C - administration & dosage Pulmonary Surfactant-Associated Protein C - therapeutic use Recombinant Proteins - administration & dosage Recombinant Proteins - therapeutic use Respiratory Distress Syndrome, Adult - drug therapy Respiratory system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!